Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
HBIO
#4524
Harvard Bioscience, Inc. - Common Stock
5.9
5
USD
-0.03%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-2.78%
Monthly Change
-3.88%
6 month change
+962.50%
Year Change
+1283.72%
Previous Close
6.1
2
Open
6.0
1
Low
5.9
0
High
6.0
1
Volume
16
Markets
US Stock Market
Healthcare
Medical Instruments & Supplies
HBIO
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
3.98 M
4.12 M
4.22 M
4.34 M
4.41 M
4.47 M
4.51 M
Valuation ratios
Enterprise value
210.82 M
331.46 M
155.67 M
266.48 M
126.24 M
57.16 M
57.37 M
Price to earnings ratio
-21.22
987.56
11.66
-67.38
-7.54
-0.52
-2.91
Price to sales ratio
1.62
2.39
0.98
2.04
0.98
0.34
0.33
Price to cash flow ratio
17.77
225.37
96.34
16.3
63.8
4.41
9.01
Price to book ratio
2.16
3.41
1.54
3.13
1.45
2.16
0.52
Enterprise value to EBITDA ratio
25.57
33.26
168.83
29.05
114.97
-1.38
5.65
Profitability ratios
Return on assets %
-0.05
-0
-0.07
-0.02
-0.1
-0.71
-0.04
Return on equity %
-0.1
-0
-0.13
-0.05
-0.2
-4.13
-0.34
Return on invested capital %
0.59
-0.34
-19.76
4.01
-18.66
-306.67
-7.91
Gross margin %
56.85
56.9
53.66
58.86
58.18
57.67
58.99
Operating margin %
0.22
1.74
-6.12
1.69
-6.6
-56.13
-5.66
EBITDA margin %
8.08
8.38
0.81
8.17
1.17
-47.94
2.58
Net margin %
-7.65
-0.24
-8.4
-3.04
-13.18
-65.51
-16.5
Liquidity ratios
Quick ratio
1.4
1.34
1.06
0.92
0.4
1.25
1.06
Current ratio
2.46
2.43
2.2
1.85
0.82
2.2
1.99
Inventory turnover
1.99
2.06
1.94
1.81
1.64
1.76
0.4
Asset turnover
0.64
0.75
0.74
0.79
0.71
1.08
0.26
Solvency ratios
Debt to assets ratio
0.3
0.28
0.3
0.22
0
0.45
0.46
Debt to equity ratio
0.6
0.54
0.6
0.42
0
2.61
3.6
Long term debt to total assets ratio
0.31
0.3
0.32
0.27
0.29
0.45
0.46
Long term debt to total equity ratio
0.63
0.58
0.65
0.5
0.58
2.61
3.6
Per share metrics
Operating cash flow per share
2.41
0.31
0.28
3.31
0.33
1.52
0.7
EBIT per share
0.06
0.51
-1.67
0.45
-1.43
-10.94
-0.02
EBITDA per share
2.13
2.47
0.22
2.16
0.25
-9.35
2.28
Total debt per share
12.5
12.05
11.37
8.69
8.58
8.08
8.1
Cash per share
2.15
1.94
1.09
1.01
0.94
1.94
1.59
Net current asset value per share
13.38
15.26
12.34
11.56
10.36
10.86
10.61
Tangible book value per share
19.84
20.67
17.44
17.23
14.55
3.09
2.25
Working capital per share
7.93
8.99
6.73
5.3
-2.26
5.92
5.28
Book value per share
19.84
20.67
17.44
17.23
14.55
3.09
2.25
News
Benchmark raises Harvard Bioscience stock price target to $6 on reverse split
Benchmark cuts Harvard Bioscience stock price target on NIH concerns
Harvard Bioscience, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:HBIO) 2026-03-13
Harvard Bioscience Q4 2025 slides: margins hit 7-quarter high
Harvard Bioscience earnings missed by $0.10, revenue topped estimates
Harvard Bioscience executes 1-for-10 reverse stock split
Harvard Bioscience reports Q4 revenue in line with guidance
What's Going On With Harvard Bioscience Stock Friday? - Harvard Bioscience (NASDAQ:HBIO)
Harvard Bioscience to close Holliston plant in manufacturing consolidation
Harvard Bioscience secures $40 million credit facility from BroadOak
Harvard Bioscience, Inc. 2025 Q3 - Results - Earnings Call Presentation (NASDAQ:HBIO) 2025-11-07
Harvard Bioscience Q3 2025 slides: EPS miss overshadows operational improvements